B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.

Daniela Asslaber; Yuan Qi; Nicole Maeding; Markus Steiner; Ursula Denk; Jan Philip Höpner; Tanja Hartmann; Nadja Zaborsky; Richard Greil; Alexander Egle

doi:10.1182/blood.2019000973

B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.

Daniela Asslaber (Erstautor/-in), Yuan Qi, Nicole Maeding, Markus Steiner (Co-Autor/-in), Ursula Denk (Co-Autor/-in), Jan Philip Höpner, Tanja Hartmann (Co-Autor/-in), Nadja Zaborsky (Co-Autor/-in), Richard Greil (Co-Autor/-in), Alexander Egle^* (Letztautor/-in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Universitätsinstitut für experimentelle und klinische Zelltherapie
Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

18 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	1729
Fachzeitschrift	BLOOD
Jahrgang	134
Ausgabenummer	20
DOIs	https://doi.org/10.1182/blood.2019000973
Publikationsstatus	Veröffentlicht - 2019

Zugriff auf Dokument

10.1182/blood.2019000973

Single cell mass spectrometry applied for multiparametric immune phenotyping with therapeutic implications in chronic lymphocytic leukemia (CLL)
Egle, A. (Leitende(r) Forscher/-in) & Asslaber, D. (CoPI)
24/05/19 → 24/05/21
Projekt: Forschung

Dieses zitieren

Asslaber, D., Qi, Y., Maeding, N., Steiner, M., Denk, U., Höpner, J. P., Hartmann, T., Zaborsky, N., Greil, R., & Egle, A. (2019). B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion. BLOOD , 134(20), 1729. https://doi.org/10.1182/blood.2019000973

Asslaber, Daniela ; Qi, Yuan ; Maeding, Nicole et al. / B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion. in: BLOOD 2019 ; Jahrgang 134, Nr. 20. S. 1729.

@article{513b5e575db9427b99eafc30f7a5c093,

title = "B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.",

keywords = "TRANSGENIC MOUSE MODEL, DENDRITIC CELLS, ACTIVATION, EXPRESSION, CLL, SUPPRESSOR, GENERATION, MUTATIONS, BETA",

author = "Daniela Asslaber and Yuan Qi and Nicole Maeding and Markus Steiner and Ursula Denk and H{\"o}pner, {Jan Philip} and Tanja Hartmann and Nadja Zaborsky and Richard Greil and Alexander Egle",

note = "all: Paracelsus Med Univ, Ctr Oncol, Dept Internal Med Haematol Med Oncol Haemostaseol, Salzburg, Austria; D.A. and Y.Q. contributed equally to this work.",

year = "2019",

doi = "10.1182/blood.2019000973",

language = "English",

volume = "134",

pages = "1729",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "20",

}

Asslaber, D, Qi, Y, Maeding, N , Steiner, M, Denk, U, Höpner, JP, Hartmann, T, Zaborsky, N , Greil, R & Egle, A 2019, 'B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.', BLOOD , Jg. 134, Nr. 20, S. 1729. https://doi.org/10.1182/blood.2019000973

B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion. / Asslaber, Daniela (Erstautor/-in); Qi, Yuan; Maeding, Nicole et al.
in: BLOOD , Jahrgang 134, Nr. 20, 2019, S. 1729.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.

AU - Asslaber, Daniela

AU - Qi, Yuan

AU - Maeding, Nicole

AU - Steiner, Markus

AU - Denk, Ursula

AU - Höpner, Jan Philip

AU - Hartmann, Tanja

AU - Zaborsky, Nadja

AU - Greil, Richard

AU - Egle, Alexander

N1 - all: Paracelsus Med Univ, Ctr Oncol, Dept Internal Med Haematol Med Oncol Haemostaseol, Salzburg, Austria; D.A. and Y.Q. contributed equally to this work.

PY - 2019

Y1 - 2019

KW - TRANSGENIC MOUSE MODEL

KW - DENDRITIC CELLS

KW - ACTIVATION

KW - EXPRESSION

KW - CLL

KW - SUPPRESSOR

KW - GENERATION

KW - MUTATIONS

KW - BETA

U2 - 10.1182/blood.2019000973

DO - 10.1182/blood.2019000973

M3 - Original Article

C2 - 31537531

SN - 0006-4971

VL - 134

SP - 1729

JO - BLOOD

JF - BLOOD

IS - 20

ER -

Asslaber D, Qi Y, Maeding N , Steiner M, Denk U, Höpner JP et al. B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion. BLOOD . 2019;134(20):1729. doi: 10.1182/blood.2019000973

B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.

Zugriff auf Dokument

Projekte

Single cell mass spectrometry applied for multiparametric immune phenotyping with therapeutic implications in chronic lymphocytic leukemia (CLL)

Dieses zitieren